financetom
Business
financetom
/
Business
/
HSG, Jane Street among investors in Kraken's September fundraising, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HSG, Jane Street among investors in Kraken's September fundraising, sources say
Oct 22, 2025 10:18 AM

(Reuters) -Apollo Global Management, Oppenheimer, Jane Street and HSG, formerly known as Sequoia Capital China, invested in crypto exchange Kraken's recent funding round that valued the company at $15 billion, said two sources familiar with the matter.

Fortune reported last month that Kraken closed the $500 million round, but Reuters is naming the firms, which are major investors and financial players, for the first time.

Their participation underscores how institutional players are moving into the digital asset sector, which has benefited from U.S. President Donald Trump's pro-crypto stance and his administration's push for friendly regulations.

Qube Research & Technologies; Kraken's co-CEO Arjun Sethi; and Tribe Capital, a venture capital firm that Sethi co-founded, also bought into the fundraising round, which paves the way for the crypto firm to go public in coming months, one source said.

Spokespeople for Kraken, Qube and Jane Street declined to comment. Spokespeople for Apollo, Oppenheimer, HSG and Tribe Capital did not provide comment.

Kraken, one of the world's largest crypto trading platforms, is expected to confidentially file a registration statement for an initial public offering with the U.S. Securities and Exchange Commission by year-end, with plans to go public in the first quarter, one of the sources added, although it was unclear how the U.S. government shutdown might affect that timeline.

Several other crypto companies including Circle, Gemini and Bullish have capitalized on crypto exuberance with IPOs this year.

Kraken has been expanding aggressively, buying retail futures trading platform NinjaTrader for $1.5 billion in May and futures exchange Small Exchange from IG Group for $100 million this month, paving the way for the company to launch a fully U.S.-based derivatives platform.

Growing institutional and corporate participation in crypto markets has helped push up the value of major tokens over the last year. Bitcoin, the world's largest cryptocurrency, is up more than 20% so far this year, after hitting a record high above $126,000 this month.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TIMELINE-Key moments in the recent history of Boeing's 737 MAX
TIMELINE-Key moments in the recent history of Boeing's 737 MAX
Jul 8, 2024
(Recasts headline) July 8 (Reuters) - Boeing ( BA ) has agreed to plead guilty to a criminal fraud conspiracy charge and pay a fine of $243.6 million to resolve a U.S. Justice Department investigation into two 737 MAX fatal crashes, the government said in a court filing on Sunday. Earlier this month, Boeing ( BA ) agreed to buy...
Oil Prices Weaken for a Second Session as Geopolitical Risk Eases and Hurricane Beryl Hits Texas
Oil Prices Weaken for a Second Session as Geopolitical Risk Eases and Hurricane Beryl Hits Texas
Jul 8, 2024
09:21 AM EDT, 07/08/2024 (MT Newswires) -- Oil prices eased early on Monday, falling for a second day on lower geopolitical risk as Iran elected a more moderate president amid ceasefire talks between Israel and Hamas, while Hurricane Beryl made landfall in Texas, closing export facilities. West Texas Intermediate crude for August delivery was last seen down US$0.52 to US$82.64...
Sellas Life Sciences' Potential Myeloid Leukemia Therapy Receives EU Orphan Drug Designation
Sellas Life Sciences' Potential Myeloid Leukemia Therapy Receives EU Orphan Drug Designation
Jul 8, 2024
09:24 AM EDT, 07/08/2024 (MT Newswires) -- Sellas Life Sciences Group ( SLS ) said Monday that the European Commission has granted orphan drug designation to its CDK9 inhibitor SLS009 to treat acute myeloid leukemia. The designation, which was based on a positive opinion from the European Medicines Agency, qualifies the company for financial and regulatory incentives, including a 10-year...
Silo Pharma Signs License Deal for Potential PTSD Treatment
Silo Pharma Signs License Deal for Potential PTSD Treatment
Jul 8, 2024
09:24 AM EDT, 07/08/2024 (MT Newswires) -- Silo Pharma ( SILO ) said Monday it has signed an exclusive global license agreement with Columbia University to further develop, manufacture and commercialize its potential intranasal treatment for stress-induced affective disorders and post-traumatic stress disorder. The company said it is currently in the final steps before submission of an investigational new drug...
Copyright 2023-2026 - www.financetom.com All Rights Reserved